POSC63 Cost-Effectiveness of Non-Statin Lipid-Modifying Agents for Primary and Secondary Prevention of Cardiovascular Disease Among Patients with Type 2 Diabetes Mellitus: A Systematic Review

Jan 1, 2022, 00:00 AM
10.1016/j.jval.2021.11.468
https://www.valueinhealthjournal.com/article/S1098-3015(21)02263-4/fulltext
Section Title :
Section Order : 11241
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02263-4&doi=10.1016/j.jval.2021.11.468
HEOR Topics :
Tags :
Regions :